Our previous study showed that CCL18 was highly expressed in tumor tissues and the serum and was also closely associated with lymph node metastasis and a poor prognosis in NSCLC patients [16], suggesting that CCL18 plays an important role in NSCLC progression, especially in tumor metastasis. This evidence concerns the gene CCL18 and non-small cell lung carcinoma.